ResearchMoz

Retail Banker Industry Report 2014

Timetric
Published Date » 2014-02-28
No. Of Pages » 112
     
  Synopsis  
   
 The definitive report on global retail banking, the Retail Banker Industry Report 2014 provides the inside track on the markets, sectors and people of the industry. 
 With sections covering products, distribution and results as well as emerging challengers, and various country reports and investigations into big banks IT systems and more, this report delivers a critical account of the retail banking industry in 2013 and what to expect in 2014. 
     
  Executive summary  
   
 With exclusive content from industry experts, comprehensive 2013 news highlights, the definitive breakdown of social media use in FS, interviews with thought leaders from across the industry, and profiles of leading banks, the Retail Banker Industry Report 2014 is a must have for...
Table of contents

News
Jan-03
Feb-05
Mar-07
Apr-09
May-11
Jun-13
Jul-15
Aug-17
Sep-19
Oct-21
Nov-23
Dec-25
Distribution
The evolution of the branch in 2013 27
Mobile Banking 31
US Branches 33
BBVA 34
Mobile Banking Latin America 35
CIBC Branch 39
Omni-Channel 40
Zuno Bank 41
Allied Irish Banks 42
ABSA LED screen 43
Marketing
UK Branding 44
Cross-sell 46
Digital Marketing 47
Facebook 48
Social Media 51
mBank 53
Digital Marketing 54
Gamification 56
Products
Credit Cards 58
Mastercard Prepaid Event 60
Current Accounts 62
Debit Cards 63
Student Current Accounts 64
Cumberland Building Society 66
Prepaid cards 67
Packaged Accounts 68
Research and Data
Sungard 71
Account Switching 72
Women in Banking 73
World Banking Report 74
Bancassurance 76
US Credit 78
US 79
Strategy
Asia 81
Predictions and Priorities 2014 82
Pop-up Branches 86
Tinkoff Credit Systems 88
Account Switching 90
MPS 93
Challenger Banks 95
MD Bank Islam 96
New Zealand’s Digital Channel 98
Technology
Mobile Cheque Deposit 100
Wincor 101
Mobile Apps 102
Tata 103
Cloud Computing 104
BYOD 106
Mobile 108
Finovate Europe 2013 109
Firserv 111

Upcoming Reports:

Fluorspar Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Fluorspar is the commercial name for the mineral fluorite (calcium fluoride CaF2). Commercially fluorspar is graded according to quality and attributes into acid grade, ceramic grade and metallurgical grade. It generally develops well formed cubic crystals exhibiting a wide range of colors. The end use is determined by the grade of the fluorspar. Almost two thirds of the world’s production of fluorspar is used for the manufacturing of hydrofluoric acid (HF). Hydrofluoric acid is used as a feedstock for the manufacturing of fluorine containing compounds like fluoropolymers and...
Molecular Spectroscopy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Spectroscopy is one of the most advanced and famous analytical technologies used extensively in large number of fields, from healthcare to manufacturing. Spectroscopy is the measurement of interaction between radiated energies emitted by certain matter. The spectroscopy is considered as a function of wavelength. In spectroscopic studies, electromagnetic radiations are allowed to pass through the sample to be analyzed; the sample molecules absorb only those wavelengths which can convert their energy level, from ground state to excited state. The detector installed on other side...
Lateral Epicondylitis (Tennis Elbow) Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020
By - Transparency Market Research
Lateral epicondylitis (tennis elbow) is a painful condition caused by the repetitive motion of arms and elbow. A kind of tendinitis, the condition involves swelling of tendons and is identified on medical examination. Lateral epicondylitis (tennis elbow) is an inflammatory condition observed usually in tennis players, baseball players, swimmers, carpenters, plumbers and anyone who repeats an arm motion over and over. Pain is localized around the lateral elbow and dorsal forearm regions. The condition aggravates on extending wrist against the resistance. Lateral epicondylitis (tennis elbow)...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Blackstone Invests $800 Million in Asian Oil-Based Energy Company
Jul 31, 2014  
Blackstone Energy Partners announced to invest $800 million in an Asian based energy company that is led by former industry executives.  Blackstone is popularly considered a part of the world’s largest administrator of alternatives to financial stocks and bonds. New York-based managing director, Angelo Acconcia of Blackstone Energy Partners said in an interview that Tamarind...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...